A Research Agenda for Malaria Eradication: Basic Science and Enabling Technologies
Today's malaria control efforts are limited by our incomplete understanding of the biology of Plasmodium and of the complex relationships between human populations and the multiple species of mosquito and parasite. Research priorities include the development of in vitro culture systems for the complete life cycle of P. falciparum and P. vivax and the development of an appropriate liver culture system to study hepatic stages. In addition, genetic technologies for the manipulation of Plasmodium need to be improved, the entire parasite metabolome needs to be characterized to identify new druggable targets, and improved information systems for monitoring the changes in epidemiology, pathology, and host-parasite-vector interactions as a result of intensified control need to be established to bridge the gap between bench, preclinical, clinical, and population-based sciences.
Vyšlo v časopise:
A Research Agenda for Malaria Eradication: Basic Science and Enabling Technologies. PLoS Med 8(1): e32767. doi:10.1371/journal.pmed.1000399
Kategorie:
Review
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000399
Souhrn
Today's malaria control efforts are limited by our incomplete understanding of the biology of Plasmodium and of the complex relationships between human populations and the multiple species of mosquito and parasite. Research priorities include the development of in vitro culture systems for the complete life cycle of P. falciparum and P. vivax and the development of an appropriate liver culture system to study hepatic stages. In addition, genetic technologies for the manipulation of Plasmodium need to be improved, the entire parasite metabolome needs to be characterized to identify new druggable targets, and improved information systems for monitoring the changes in epidemiology, pathology, and host-parasite-vector interactions as a result of intensified control need to be established to bridge the gap between bench, preclinical, clinical, and population-based sciences.
Zdroje
1. The malERA Consultative Group on Vaccines 2011 A research agenda for malaria eradication: Vaccines. PLoS Med 8 e1000398 doi:10.1371/journal.pmed.1000398
2. The malERA Consultative Group on Drugs 2011 A research agenda for malaria eradication: Drugs. PLoS Med 8 e1000402 doi:10.1371/journal.pmed.1000402
3. The malERA Consultative Group on Diagnoses and Diagnostics 2011 A research agenda for malaria eradication: Diagnoses and diagnostics. PLoS Med 8 e1000396 doi:10.1371/journal.pmed.1000396
4. SindenRE
HartleyRH
WingerL
1985 The development of Plasmodium ookinetes in vitro: an ultrastructural study including a description of meiotic division. Parasitology 91 227 244
5. CarterEH
SuhrbierA
BeckersPJ
SindenRE
1987 The in vitro cultivation of P. falciparum ookinetes, and their enrichment on nycodenz density gradients. Parasitology 95 25 30
6. SuwanabunN
SattabongkotJ
TsuboiT
ToriiM
ManeechaiN
2001 Development of a method for the in vitro production of Plasmodium vivax ookinetes. J Parasitol 87 928 930
7. HurdH
Al-OlayanE
ButcherGA
2003 In vitro methods for culturing vertebrate and mosquito stages of Plasmodium. Microbes Infect 5 321 327
8. Porter-KelleyJM
DinglasanRR
AlamU
NdetaGA
SacciJBJr
2006 Plasmodium yoelii: Axenic development of the parasite mosquito stages. Exp Parasitol 112 99 108
9. DinglasanRR
AlagananA
GhoshAK
SaitoA
van KuppeveltTH
2007 Plasmodium falciparum ookinetes require mosquito midgut chondroitin sulfate proteoglycans for cell invasion. Proc Natl Acad Sci U S A 104 15882 15887
10. GhoshAK
DinglasanRR
IkadaiH
Jacobs-LorenaM
2010 An improved method for the in vitro differentiation of Plasmodium falciparum gametocytes into ookinetes. Malar J 9 194
11. WilkinsS
BillingsleyPF
2010 Mosquito cell line glycoproteins: An unsuitable model system for the plasmodium ookinete-mosquito midgut interaction? Parasit Vectors 3 22
12. TragerW
JensenJB
2005 Human malaria parasites in continuous culture. 1976. J Parasitol 91 484 486
13. GiarratanaMC
KobariL
LapillonneH
ChalmersD
KigerL
2005 Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 23 69 74
14. DornI
Lazar-KarstenP
BoieS
RibbatJ
HartwigD
2008 In vitro proliferation and differentiation of human CD34+ cells from peripheral blood into mature red blood cells with two different cell culture systems. Transfusion 48 1122 1132
15. PanichakulT
SattabongkotJ
ChotivanichK
SirichaisinthopJ
CuiL
2007 Production of erythropoietic cells in vitro for continuous culture of Plasmodium vivax. Int J Parasitol 37 1551 1557
16. UdomsangpetchR
SomsriS
PanichakulT
ChotivanichK
SirichaisinthopJ
2007 Short-term in vitro culture of field isolates of Plasmodium vivax using umbilical cord blood. Parasitol Int 56 65 69
17. UdomsangpetchR
KanekoO
ChotivanichK
SattabongkotJ
2008 Cultivation of Plasmodium vivax. Trends Parasitol 24 85 88
18. CuiL
TrongnipattN
SattabongkotJ
UdomsangpetchR
2009 Culture of exoerythrocytic stages of the malaria parasites Plasmodium falciparum and Plasmodium vivax. Methods Mol Biol 470 263 273
19. DouayL
LapillonneH
TurhanAG
2009 Stem cells–a source of adult red blood cells for transfusion purposes: Present and future. Crit Care Clin 25 383 98, Table of Contents
20. PrudencioM
RodriguezA
MotaMM
2006 The silent path to thousands of merozoites: The Plasmodium liver stage. Nat Rev Microbiol 4 849 856
21. ChongCR
ChenX
ShiL
LiuJO
SullivanDJJr
2006 A clinical drug library screen identifies astemizole as an antimalarial agent. Nat Chem Biol 2 415 416
22. BanieckiML
WirthDF
ClardyJ
2007 High-throughput plasmodium falciparum growth assay for malaria drug discovery. Antimicrob Agents Chemother 51 716 723
23. DeuE
LeyvaMJ
AlbrowVE
RiceMJ
EllmanJA
2010 Functional studies of Plasmodium falciparum dipeptidyl aminopeptidase I using small molecule inhibitors and active site probes. Chem Biol 17 808 819
24. GamoFJ
SanzLM
VidalJ
de CozarC
AlvarezE
2010 Thousands of chemical starting points for antimalarial lead identification. Nature 465 305 310
25. GuiguemdeWA
ShelatAA
BouckD
DuffyS
CrowtherGJ
2010 Chemical genetics of Plasmodium falciparum. Nature 465 311 315
26. KatoN
SakataT
BretonG
Le RochKG
NagleA
2008 Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility. Nat Chem Biol 4 347 356
27. CrowtherGJ
NapuliAJ
GilliganJH
GagaringK
BorboaR
2010 Identification of inhibitors for putative malaria drug targets among novel antimalarial compounds. Mol Biochem Parasitol 175 21 29
28. VanBuskirkKM
O'NeillMT
De La VegaP
MaierAG
KrzychU
2009 Preerythrocytic, live-attenuated Plasmodium falciparum vaccine candidates by design. Proc Natl Acad Sci U S A 106 13004 13009
29. MuellerAK
CamargoN
KaiserK
AndorferC
FrevertU
2005 Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. Proc Natl Acad Sci U S A 102 3022 3027
30. SnooksMJ
BhatP
MackenzieJ
CounihanNA
VaughanN
2008 Vectorial entry and release of hepatitis A virus in polarized human hepatocytes. J Virol 82 8733 8742
31. MeeCJ
GroveJ
HarrisHJ
HuK
BalfeP
2008 Effect of cell polarization on hepatitis C virus entry. J Virol 82 461 470
32. PlossA
KhetaniSR
JonesCT
SyderAJ
TrehanK
2010 Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A 107 3141 3145
33. de JongYP
RiceCM
PlossA
2010 New horizons for studying human hepatotropic infections. J Clin Invest 120 650 653
34. KhetaniSR
BhatiaSN
2008 Microscale culture of human liver cells for drug development. Nat Biotechnol 26 120 126
35. de JongYP
RiceCM
PlossA
2010 New horizons for studying human hepatotropic infections. J Clin Invest 120 650 653
36. The malERA Consultative Group on Monitoring, Evaluation, and Surveillance 2011 A research agenda for malaria eradication: Monitoring, evaluation, and surveillance. PLoS Med 8 e1000400 doi:10.1371/journal.pmed.1000400
37. HerreraS
PerlazaBL
BoneloA
Arevalo-HerreraM
2002 Aotus monkeys: their great value for anti-malaria vaccines and drug testing. Int J Parasitol 32 1625 1635
38. NtumngiaFB
McHenryAM
BarnwellJW
Cole-TobianJ
KingCL
2009 Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development. Am J Trop Med Hyg 80 218 227
39. CollinsWE
SullivanJS
JefferyGM
WilliamsA
GallandGG
2009 The chesson strain of Plasmodium vivax in humans and different species of Aotus monkeys. Am J Trop Med Hyg 80 152 159
40. MaierAG
RugM
O'NeillMT
BrownM
ChakravortyS
2008 Exported proteins required for virulence and rigidity of Plasmodium falciparum-infected human erythrocytes. Cell 134 48 61
41. JanseCJ
RamesarJ
WatersAP
2006 High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat Protoc 1 346 356
42. ArmstrongCM
GoldbergDE
2007 An FKBP destabilization domain modulates protein levels in Plasmodium falciparum. Nat Methods 4 1007 1009
43. BaluB
ChauhanC
MaherSP
ShoueDA
KissingerJC
2009 piggyBac is an effective tool for functional analysis of the Plasmodium falciparum genome. BMC Microbiol 9 83
44. CombeA
GiovanniniD
CarvalhoTG
SpathS
BoissonB
2009 Clonal conditional mutagenesis in malaria parasites. Cell Host Microbe 5 386 396
45. SchnutgenF
De-ZoltS
Van SlounP
HollatzM
FlossT
2005 Genomewide production of multipurpose alleles for the functional analysis of the mouse genome. Proc Natl Acad Sci U S A 102 7221 7226
46. LangridgeGC
PhanMD
TurnerDJ
PerkinsTT
PartsL
2009 Simultaneous assay of every Salmonella typhi gene using one million transposon mutants. Genome Res 19 2308 2316
47. WinzelerEA
ShoemakerDD
AstromoffA
LiangH
AndersonK
1999 Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 285 901 906
48. GiaeverG
ChuAM
NiL
ConnellyC
RilesL
2002 Functional profiling of the Saccharomyces cerevisiae genome. Nature 418 387 391
49. ParsonsAB
LopezA
GivoniIE
WilliamsDE
GrayCA
2006 Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 126 611 625
50. GardnerMJ
HallN
FungE
WhiteO
BerrimanM
2002 Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419 498 511
51. PainA
BohmeU
BerryAE
MungallK
FinnRD
2008 The genome of the simian and human malaria parasite Plasmodium knowlesi. Nature 455 799 803
52. CarltonJM
AdamsJH
SilvaJC
BidwellSL
LorenziH
2008 Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 455 757 763
53. AurrecoecheaC
HeigesM
WangH
WangZ
FischerS
2007 ApiDB: Integrated resources for the apicomplexan bioinformatics resource center. Nucleic Acids Res 35 D427 D430
54. HoltRA
SubramanianGM
HalpernA
SuttonGG
CharlabR
2002 The genome sequence of the malaria mosquito Anopheles gambiae. Science 298 129 149
55. GardinerDL
Skinner-AdamsTS
BrownCL
AndrewsKT
StackCM
2009 Plasmodium falciparum: New molecular targets with potential for antimalarial drug development. Expert Rev Anti Infect Ther 7 1087 1098
56. KafsackBF
LlinasM
2010 Eating at the table of another: Metabolomics of host-parasite interactions. Cell Host Microbe 7 90 99
57. OlszewskiKL
LlinasM
2010 Central carbon metabolism of plasmodium parasites. Mol Biochem Parasitol. In press
58. OlszewskiKL
MatherMW
MorriseyJM
GarciaBA
VaidyaAB
2010 Branched tricarboxylic acid metabolism in Plasmodium falciparum. Nature 466 774 778
59. OlszewskiKL
MorriseyJM
WilinskiD
BurnsJM
VaidyaAB
2009 Host-parasite interactions revealed by Plasmodium falciparum metabolomics. Cell Host Microbe 5 191 199
60. TengR
JunankarPR
BubbWA
RaeC
MercierP
2009 Metabolite profiling of the intraerythrocytic malaria parasite Plasmodium falciparum by (1)H NMR spectroscopy. NMR Biomed 22 292 302
61. BesteiroS
Vo DuyS
PerigaudC
Lefebvre-TournierI
VialHJ
2010 Exploring metabolomic approaches to analyse phospholipid biosynthetic pathways in Plasmodium. Parasitology 137 1343 1356
62. HuntP
MartinelliA
ModrzynskaK
BorgesS
CreaseyA
2010 Experimental evolution, genetic analysis and genome re-sequencing reveal the mutation conferring artemisinin resistance in an isogenic lineage of malaria parasites. BMC Genomics 11 499
63. DondorpAM
NostenF
YiP
DasD
PhyoAP
2009 Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361 455 467
64. The malERA Consultative Group on Modeling 2011 A research agenda for malaria eradication: Modeling. PLoS Med 8 e1000403 doi:10.1371/journal.pmed.1000403
65. DailyJP
ScanfeldD
PochetN
Le RochK
PlouffeD
2007 Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature 450 1091 1095
66. Arastu-KapurS
PonderEL
FonovicUP
YeohS
YuanF
2008 Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum. Nat Chem Biol 4 203 213
67. ArezAP
PintoJ
PalssonK
SnounouG
JaensonTG
2003 Transmission of mixed Plasmodium species and Plasmodium falciparum genotypes. Am J Trop Med Hyg 68 161 168
68. BousemaJT
DrakeleyCJ
MensPF
ArensT
HoubenR
2008 Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae. Am J Trop Med Hyg 78 442 448
69. OsierFH
FeganG
PolleySD
MurungiL
VerraF
2008 Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. Infect Immun 76 2240 2248
70. CromptonPD
KayalaMA
TraoreB
KayentaoK
OngoibaA
2010 A prospective analysis of the ab response to Plasmodium falciparum before and after a malaria season by protein microarray. Proc Natl Acad Sci U S A 107 6958 6963
71. The malERA Consultative Group on Vector Control 2011 A research agenda for malaria eradication: Vector control. PLoS Med 8 e1000401 doi:10.1371/journal.pmed.1000401
72. LawpoolsriS
KleinEY
SinghasivanonP
YimsamranS
ThanyavanichN
2009 Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity thai-myanmar border populations. Malar J 8 159
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2011 Číslo 1
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- A Research Agenda for Malaria Eradication: Cross-Cutting Issues for Eradication
- The Impact of eHealth on the Quality and Safety of Health Care: A Systematic Overview
- Estimates of Pandemic Influenza Vaccine Effectiveness in Europe, 2009–2010: Results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) Multicentre Case-Control Study
- Using the Delphi Technique to Determine Which Outcomes to Measure in Clinical Trials: Recommendations for the Future Based on a Systematic Review of Existing Studies